______ is a hormone produced by the kidneys to stimulate the production of red blood cells. It ensures normal oxygen levels in the mother and fetus.

1. A

   Cortisol

2. B

   Thyroxine

3. C

   Insulin

4. D

   Erythropoietin

Appeared in: MP NHM CHO-2024 (Shift-2)

Explanation

• Erythropoietin (EPO) is a glycoprotein hormone that is the primary regulator of red blood cell (RBC) production, a process called erythropoiesis.
• Approximately 90% of EPO is produced by specialized cells in the kidneys in response to tissue hypoxia (low oxygen levels).
• EPO stimulates the bone marrow to increase the proliferation and maturation of erythroid progenitor cells into mature red blood cells.
• This mechanism is vital for maintaining adequate oxygen-carrying capacity in the blood, which is especially important during pregnancy to support both maternal and fetal oxygen needs.

Why Other Options Were Wrong

• Option A: Cortisol is a steroid hormone produced by the adrenal glands. Its primary roles are in the body's response to stress, regulating metabolism, and suppressing inflammation. It does not directly stimulate red blood cell production.
• Option B: Thyroxine (T4) is produced by the thyroid gland and is essential for regulating the body's basal metabolic rate. While severe hypothyroidism can lead to anemia, thyroxine is not the primary hormone responsible for stimulating erythropoiesis.
• Option C: Insulin is a peptide hormone produced by the beta cells of the pancreas. Its main function is to regulate blood glucose levels by promoting the uptake of glucose into cells. It has no direct role in red blood cell production.

Related Visual

• Visual 1: Diagram: The Erythropoietin Feedback Loop. This visual would show how low blood oxygen (hypoxia) is detected by the kidneys, leading to EPO secretion, which then stimulates the bone marrow to produce more RBCs, ultimately increasing blood oxygen levels and creating a negative feedback.

Clinical Relevance

• Nursing practice connection: Knowing Hormonal regulation of red blood cell production (erythropoiesis) helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
• Nurses frequently care for patients with chronic kidney disease (CKD) who develop anemia because their damaged kidneys cannot produce enough EPO. Understanding this link is crucial for patient assessment and education.
• The administration of synthetic erythropoietin-stimulating agents (ESAs) is a key nursing intervention for managing anemia in CKD and chemotherapy patients. Nurses must monitor for therapeutic effects (increased hemoglobin) and adverse effects (hypertension, thrombosis).
• During pregnancy, nurses monitor for physiological anemia. While usually due to plasma volume expansion, understanding the role of EPO helps differentiate it from other causes of anemia that might require intervention.

How to Approach the Question

• First, break down the question to identify the key defining characteristics: 1) it's a hormone, 2) it's produced by the kidneys, and 3) it stimulates red blood cell production.
• Next, systematically review each option against these three criteria.
• Eliminate Cortisol: It's from the adrenal gland and primarily for stress/metabolism.
• Eliminate Thyroxine: It's from the thyroid gland and for metabolism.
• Eliminate Insulin: It's from the pancreas and for glucose regulation.
• Confirm Erythropoietin: The prefix 'erythro-' relates to red blood cells (erythrocytes), and 'poiesis' means formation. This hormone is known to be produced by the kidneys to stimulate erythropoiesis.

Concept Tested & Keywords

• Concept Tested: Hormonal regulation of red blood cell production (erythropoiesis).
• Stem keywords: hormone, kidneys, stimulate, production of red blood cells, oxygen levels, mother, fetus
• Lead-in keywords: is a
• Negative lead-in flag: false

Question ID

QgdJrWeMubLiEBp4emkXhG

Copy ID